Showing results (241-250 of 272) with videos related to

Sort By:
Pageof 28
Cancers|February 26, 2025
K-Means Clustering of Hyperpolarised <sup>13</sup>C-MRI Identifies Intratumoral Perfusion/Metabolism Mismatch in Renal Cell Carcinoma as the Best Predictor of the Highest GradeInes Horvat-Menih, Alixander S Khan, Mary A McLean, et al.
Circulation. Cardiovascular Imaging|March 25, 2015
Cardiac magnetic resonance myocardial perfusion reserve index is reduced in women with coronary microvascular dysfunction. A National Heart, Lung, and Blood Institute-sponsored study from the Women's Ischemia Syndrome EvaluationLouise E J Thomson, Janet Wei, Megha Agarwal, et al.
Cell|August 26, 2017
Heterogeneous Tumor-Immune Microenvironments among Differentially Growing Metastases in an Ovarian Cancer PatientAlejandro Jiménez-Sánchez, Danish Memon, Stephane Pourpe, et al.
Molecular Cancer Therapeutics|June 3, 2022
Trastuzumab Deruxtecan, Antibody-Drug Conjugate Targeting HER2, Is Effective in Pediatric Malignancies: A Report by the Pediatric Preclinical Testing ConsortiumPooja Hingorani, Wendong Zhang, Zhongting Zhang, et al.
European Radiology Experimental|July 9, 2024
High-resolution and highly accelerated MRI T2 mapping as a tool to characterise renal tumour subtypes and gradesInes Horvat-Menih, Hao Li, Andrew N Priest, et al.
NMR in Biomedicine|June 24, 2026
Estimating the Sodium Content: A Case Series of Benign and Malignant Renal Tumours Using <sup>23</sup>Na-MRI at 3 TInes Horvat-Menih, Jonathan R Birchall, Maria J Zamora-Morales, et al.
Cancer Research|August 8, 2015
Carbonic Anhydrase Activity Monitored In Vivo by Hyperpolarized 13C-Magnetic Resonance Spectroscopy Demonstrates Its Importance for pH Regulation in TumorsFerdia A Gallagher, Helen Sladen, Mikko I Kettunen, et al.
Journal for Immunotherapy of Cancer|September 25, 2021
Multiparametric MRI of early tumor response to immune checkpoint blockade in metastatic melanomaDoreen Lau, Mary A McLean, Andrew N Priest, et al.
Scientific Reports|July 26, 2019
Diffusion kurtosis MRI as a predictive biomarker of response to neoadjuvant chemotherapy in high grade serous ovarian cancerSurrin S Deen, Andrew N Priest, Mary A McLean, et al.
BMJ Open|October 26, 2024
Multiarm, non-randomised, single-centre feasibility study-investigation of the differential biology between benign and malignant renal masses using advanced magnetic resonance imaging techniques (IBM-Renal): protocolInes Horvat-Menih, Mary A McLean, Maria Jesus Zamora-Morales, et al.
Pageof 28